SEARCH

SEARCH BY CITATION

References

  • Ahboucha S. and Butterworth R. F. (2007) The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy. Metab. Brain Dis. 22, 291308.
  • Ahboucha S. and Butterworth R. F. (2008) The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy. Neurochem. Int. 52, 575587.
  • Ahboucha S., Pomier-Layrargues G., Mamer O. and Butterworth R. F. (2006) Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma. Neurochem. Int. 49, 372378.
  • Azorín I., Miñana M. D., Felipo V. and Grisolía S. (1989) A simple animal model for hyperammonemia. Hepatology 10, 314.
  • Baulieu E. E. (1998) Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23, 963987.
  • Belelli D. and Lambert J. J. (2005) Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat. Rev. Neurosci. 6, 565575.
  • Boix J., Llansola M., Cabrera-Pastor A. and Felipo V. (2011) Metabotropic glutamate receptor 5 modulates the nitric oxide-cGMP pathway in cerebellum in vivo through activation of AMPA receptors. Neurochem. Int. 58, 599604.
  • Cauli O., Llansola M., Erceg S. and Felipo V. (2006) Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra. J. Hepatol. 45, 654661.
  • Cauli O., Rodrigo R., Piedrafita B., Boix J. and Felipo V. (2007) Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts. Hepatology 46, 514519.
  • Cauli O., Mansouri M. T., Agusti A. and Felipo V. (2009) Hyperammonemia increases GABAergic tone in the cerebellum but decreases it in the rat cortex. Gastroenterology 136, 13591367.
  • Cauli O., González-Usano A., Agustí A. and Felipo V. (2011) Differential modulation of the glutamate-nitric oxide-cyclic GMP pathway by distinct neurosteroids in cerebellum in vivo. Neuroscience 190, 2736.
  • Compagnone N. A. and Mellon S. H. (2000) Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 21, 156.
  • Corpéchot C., Robel P., Axelson M., Sjövall J. and Baulieu E. E. (1981) Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl Acad. Sci. USA 78, 47044707.
  • El Mlili N., Boix J., Ahabrach H., Rodrigo R., Errami M. and Felipo V. (2010) Chronic hyperammonemia induces tonic activation of NMDA receptors in cerebellum. J. Neurochem. 112, 10051014.
  • Engel S. R., Purdy R. H. and Grant K. A. (2001) Characterization of discriminative stimulus effects of the neuroactive steroid pregnanolone. J. Pharmacol. Exp. Ther. 297, 489495.
  • Erceg S., Monfort P., Hernández-Viadel M., Rodrigo R., Montoliu C. and Felipo V. (2005a) Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunt. Hepatology 45, 210.
  • Erceg S., Monfort P., Hernandez-Viadel M., Llansola M., Montoliu C. and Felipo V. (2005b) Restoration of learning ability in hyperammonemic rats by increasing extracellular cGMP in brain. Brain Res. 1036, 115121.
  • Ermirio R., Blanchi D., Ruggeri P., Cogo C. E. and Molinari C. (1989) Actions of 3 alpha,5 alpha-tetrahydrodeoxycorticosterone on single neurones of the mesencephalic reticular formation in the rat. Neurosci. Lett. 104, 115120.
  • Fedele E. and Raiteri M. (1996) Desensitization of AMPA receptors and AMPA-NMDA receptor interaction: an in vivo cyclic GMP microdialysis study in rat cerebellum. Br. J. Pharmacol. 117, 11331138.
  • Fedele E., Varnier G. and Raiteri M. (1997) In vivo microdialysis study of GABA(A) and GABA(B) receptors modulating the glutamate receptor/NO/cyclic GMP pathway in the rat hippocampus. Neuropharmacology 36, 14051415.
  • Fedele E., Ansaldo M. A., Varnier G. and Raiteri M. (2000) Benzodiazepine-sensitive GABA(A) receptors limit the activity of the NMDA/NO/cyclic GMP pathway: a microdialysis study in the cerebellum of freely moving rats. J. Neurochem. 75, 782787.
  • Felipo V. and Butterworth R. F. (2002) Neurobiology of ammonia. Prog. Neurobiol. 67, 259279.
  • Felipo V., Miñana M. D. and Grisolía S. (1988) Long term ingestion of ammonium increases acetylglutamate and urea levels without affecting the amount of carbamyl phosphate synthase. Eur. J. Biochem. 176, 571.
  • Frye C. A. and Walf A. A. (2008) Effects of progesterone administration and APPswe+PSEN1Deltae9 mutation for cognitive performance of mid-aged mice. Neurobiol. Learn. Mem. 89, 1726.
  • Gasior M., Carter R. B., Goldberg S. R. and Witkin J. M. (1997) Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam. J. Pharmacol. Exp. Ther. 282, 543553.
  • Hermenegildo C., Montoliu C., Llansola M., Muñoz M. D., Gaztelu J. M., Miñana M. D. and Felipo V. (1998) Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo. Eur. J. Neurosci. 10, 32013209.
  • Izumi Y., Murayama K., Tokuda K., Krishnan K., Covey D. F. and Zorumski C. F. (2007) GABAergic neurosteroids mediate the effects of ethanol on long-term potentiation in rat hippocampal slices. Eur. J. Neurosci. 26, 18811888.
  • Kawato S., Yamada M. and Kimoto T. (2003) Brain neurosteroids are 4th generation neuromessengers in the brain: Cell biophysical analysis of steroid signal transduction. Adv. Biophys. 37, 148.
  • Lambert J. J., Belelli D., Hill-Venning C. and Peters J. A. (1995) Neurosteroids and GABAA receptor function. Trends Pharmacol. Sci. 16, 295303.
  • Llansola M., Hernandez-Viadel M., Erceg S., Montoliu C. and Felipo V. (2009) Increasing the function of the glutamate-nitric oxide-cyclic guanosine monophosphate pathway increases the ability to learn a Y-maze task. J. Neurosci. Res. 87, 23512355.
  • Luchetti S., Bossers K., Frajese G. V. and Swaab D. F. (2010) Neurosteroid biosynthetic pathway changes in substantia nigra and caudate nucleus in Parkinson's disease. Brain Pathol. 20, 945951.
  • Majewska M. D., Harrison N. L., Schwartz R. D., Barker J. L. and Paul S. M. (1986) Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232, 10041007.
  • Malayev A., Gibbs T. T. and Farb D. H. (2002) Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids. Br. J. Pharmacol. 135, 901909.
  • Marx C. E., Trost W. T., Shampine L. J. et al. (2006) The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer's disease. Biol. Psychiatry 60, 12871294.
  • Maurice T., Junien J. L. and Privat A. (1997) Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via sigma 1-receptors. Behav. Brain Res. 83, 159164.
  • Maurice T., Phan V. L., Urani A., Kamei H., Noda Y. and Nabeshima T. (1999) Neuroactive neurosteroids as endogenous effectors for the sigma1 (sigma1) receptor: pharmacological evidence and therapeutic opportunities. Jpn. J. Pharmacol. 81, 125155.
  • Monnet F. P., Mahé V., Robel P. and Baulieu E. E. (1995) Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc. Natl Acad. Sci. USA 92, 37743778.
  • Park-Chung M., Wu F. S. and Farb D. H. (1994) 3 alpha-Hydroxy-5 beta-pregnan-20-one sulfate: a negative modulator of the NMDA-induced current in cultured neurons. Mol. Pharmacol. 46, 146150.
  • Paul S. M. and Purdy R. H. (1992) Neuroactive steroids. FASEB J. 6, 23112322.
  • Rao T. S., Cler J. A., Mick S. J., Ragan D. M., Lanthorn T. H., Contreras P. C., Iyengar S. and Wood P. L. (1990) Opipramol, a potent sigma ligand, is an anti-ischemic agent: neurochemical evidence for an interaction with the N-methyl-D-aspartate receptor complex in vivo by cerebellar cGMP measurements. Neuropharmacology 29, 11991204.
  • Ritsner M. S. and Strous R. D. (2010) Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA. J. Psychiatr. Res. 44, 7580.
  • Rodrigo R., Cauli O., Gomez-Pinedo U., Agusti A., Hernandez-Rabaza V., Garcia-Verdugo J. M. and Felipo V. (2010) Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology 139, 675684.
  • Romieu P., Martin-Fardon R., Bowen W. D. and Maurice T. (2003) Sigma 1 receptor-related neuroactive steroids modulate cocaine-induced reward. J. Neurosci. 23, 35723576.
  • Romieu P., Lucas M. and Maurice T. (2006) Sigma1 receptor ligands and related neuroactive steroids interfere with the cocaine-induced state of memory. Neuropsychopharmacology 31, 14311443.
  • Rupprecht R. (1997) The neuropsychopharmacological potential of neuroactive steroids. J. Psychiatr. Res. 31, 297314.
  • Rupprecht R. and Holsboer F. (2001) Neuroactive steroids in neuropsychopharmacology. Int. Rev. Neurobiol. 46, 461477.
  • Saulskaya N. B. and Fofonova N. V. (2006) Effects of N-methyl-D-aspartate on extracellular citrulline level in the rat nucleus accumbens. Neurosci. Lett. 407, 9195.
  • Tsaousidou M. K., Ouahchi K., Warner T. T. et al. (2008) Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration. Am. J. Hum. Genet. 82, 510515.
  • Wang C., Marx C. E., Morrow A. L., Wilson W. A. and Moore S. D. (2007) Neurosteroid modulation of GABAergic neurotransmission in the central amygdala: a role for NMDA receptors. Neurosci. Lett. 415, 118123.
  • Weill-Engerer S., David J. P., Sazdovitch V., Liere P., Eychenne B., Pianos A., Schumacher M., Delacourte A., Baulieu E. E. and Akwa Y. (2002) Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. J. Clin. Endocrinol. Metab. 87, 51385143.
  • Wood P. L. and Rao T. S. (1991) A review of in vivo modulation of cerebellar cGMP levels by excitatory amino acid receptors: role of NMDA, quisqualate and kainate subtypes. Prog. Neuropsychopharmacol. Biol. Psychiatry 15, 229235.
  • Wu F. S., Gibbs T. T. and Farb D. H. (1991) Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol. Pharmacol. 40, 333336.
  • Yamada K., Hiramatsu M., Noda Y., Mamiya T., Murai M., Kameyama T., Komori Y., Nikai T., Sugihara H. and Nabeshima T. (1996) Role of nitric oxide and cyclic GMP in the dizocilpine-induced impairment of spontaneous alternation behavior in mice. Neuroscience 74, 365374.
  • Yoon S. Y., Roh D. H., Seo H. S., Kang S. Y., Moon J. Y., Song S., Beitz A. J. and Lee J. H. (2010) (2010) An increase in spinal dehydroepiandrosterone sulfate (DHEAS) enhances NMDA-induced pain via phosphorylation of the NR1 subunit in mice: Involvement of the sigma-1 receptor. Neuropharmacology 59, 460467.
  • Zheng P. (2009) Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Prog. Neurobiol. 89, 134152.